Literature DB >> 19961825

Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction.

Gang Chen1, Peter Kronenberger, Ijeoma Adaku Umelo, Erik Teugels, Jacques De Grève.   

Abstract

A simple and sensitive real-time reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) was developed to quantify threonine-to-methionine substitution at amino acid position 790 (T790M) mutant transcripts in a wild-type (wt) epidermal growth factor receptor background. The assay is based on three unmodified oligonucleotides, and both SYBR Green and a Taqman probe can be used. To increase the discrimination between mutant and wt signals, ARMS (amplification refractory mutation system) and LNA (locked nucleic acid) primers were tested, but a benefit was observed only with plasmids and not with cellular complementary DNA. The RT-qPCR assay using transcript-specific primers can detect as few as 1% T790M transcripts in a wt background and, therefore, will be useful in RNA interference studies specifically targeting mutant RNA. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961825     DOI: 10.1016/j.ab.2009.11.034

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.

Authors:  R Tang; T Zhong; Y Dang; X Zhang; P Li; G Chen
Journal:  Clin Transl Oncol       Date:  2015-08-26       Impact factor: 3.405

2.  MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.

Authors:  Rongquan He; Lihua Yang; Xiaomiao Lin; Xin Chen; Xinggu Lin; Fanglin Wei; Xiaona Liang; Yihuan Luo; Yuzhuang Wu; Tingqing Gan; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

3.  Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.

Authors:  Gang Chen; Peter Kronenberger; Erik Teugels; Ijeoma Adaku Umelo; Jacques De Grève
Journal:  BMC Med       Date:  2012-03-21       Impact factor: 8.775

4.  An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps.

Authors:  Xin Zhang; Wei Tang; Gang Chen; Fanghui Ren; Haiwei Liang; Yiwu Dang; Minhua Rong
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

5.  Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET.

Authors:  Yiwu Dang; Dianzhong Luo; Minhua Rong; Gang Chen
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

6.  Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.

Authors:  Minhua Rong; Gang Chen; Yiwu Dang
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

7.  Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib.

Authors:  Gang Chen; Alfiah Noor; Peter Kronenberger; Erik Teugels; Ijeoma Adaku Umelo; Jacques De Grève
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

8.  miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.

Authors:  Gang Chen; Ijeoma Adaku Umelo; Shasha Lv; Erik Teugels; Karel Fostier; Peter Kronenberger; Alex Dewaele; Jan Sadones; Caroline Geers; Jacques De Grève
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.

Authors:  Ruixue Tang; Lu Liang; Dianzhong Luo; Zhenbo Feng; Qiuxia Huang; Rongquan He; Tingqing Gan; Lihua Yang; Gang Chen
Journal:  Med Sci Monit       Date:  2015-08-25

10.  Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.

Authors:  Suning Huang; Rongquan He; Minhua Rong; Yiwu Dang; Gang Chen
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.